You just read:

Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy

News provided by

Immunomic Therapeutics, Inc.

May 03, 2012, 11:05 ET